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1 Aim of the PhD Project 
 
The aim of this PhD thesis was to investigate the time course and the sensory changes induced by 
UVB inflammation and clarify the existence of possible convergence between skin and deep tissues. 
In particular this thesis is focused on the following objectives: 
1st objective: to evaluate the change in sensitivity after inflammation inside and outside the 
irradiated skin and to investigate whether UVB-induced cutaneous inflammation would enhance the 
pain responses from the underlying deep somatic areas;  
2nd objective: to evaluate any possible convergence or cumulative effects between cutaneous and 
deep-tissue hyperalgesia by combining UVB cutaneous model of hyperalgesia with intramuscular 
sensitization evoked by delayed-onset muscle soreness (DOMS);  
3rd objective: to further investigate the pattern of mechanical hyperalgesia and allodynia induced by 
UVB irradiation by application of repeated heat stimuli and whether sensitization of the deep tissues 
underlying UVB-irradiated skin might alter the response of the UVB-model to heat rekindling. 
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2 PhD studies 
 
Based on the objectives of the thesis, three studies were designed and performed. The study 1 dealt 
with the first objective, whereas study 2 and study 3 of the thesis dealt with the second and third 
objectives, respectively. 
 
Study 1: Hyperalgesia and allodynia to superficial and deep-tissue mechanical stimulation within 
and outside a UVB-irradiated skin area. 
 
In the Study 1, the ultraviolet-B (UVB) inflammatory model was applied on the skin of healthy 
subjects in order to investigate 1) changes in cutaneous vaso-responses induced by UVB-induced 
inflammation, 2) changes in mechanical pain sensitivity within and outside the UVB-induced 
inflammatory area, and 3) the effect of topical anesthesia on the UVB-induced primary and 
secondary hyperalgesia. 
 
Study 2: Combined inflammatory pain models in skin and deep tissues. 
 
In the Study 2, in order to investigate the existence of convergent facilitation between cutaneous 
and deep tissues hyperalgesia, the UVB cutaneous inflammatory model was combined with 
delayed-onset muscle soreness (DOMS) produced by eccentric activity in the muscle tissue below 
the UVB-irradiated skin. 
 
Study 3: Heat-rekindling in UVB-irradiated skin and NGF-sensitized muscle: experimental models 
of prolonged mechanical hypersensitivity. 
 
The Study 3 was designed to test the efficacy of repeated heat stimuli on mechanical sensitivity on 
the UVB model alone and in combination with nerve growth factor (NGF) sensitized muscle. In this 
third study, to allow the development of a full inflammatory response after UVB irradiation, the 
muscle soreness was induced 24 h after irradiation. To avoid mechanical stretching of the injured 
skin caused by the eccentric contractions, a different method was selected for the induction of deep 
tissues hyperalgesia. Since one of the most supported theories about DOMS indicates the NGF as 
one of the fundamental substance implicated in the development of muscle soreness induced by 
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DOMS (Murase et al., 2010), the cutaneous UVB-model was applied in combination with NGF-
induced muscle soreness. This study was designed in order to investigate: 1) whether heat 
application would either maintain or enlarge the areas of allodynia and hyperalgesia induced by the 
UVB model, 2) whether heat rekindling could have a different effect on sensitivity when tested on 
the area of allodynia or hyperalgesia, 3) whether the combination between UVB-model and NGF-
induced muscle sensitization may change the responsiveness of UVB-irradiated skin to heat 
rekindling.  
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3 The PhD study structure 
 
 
 
  
UVB MODEL
REKINDLING 
(STUDY III)
DEEP 
TISSUES PAIN 
(STUDIES I,II)
CUTANEOUS 
VASOMOTOR 
REACTION 
(STUDIES I,II)
SECONDARY 
HYPERALGESIA 
(STUDIES I, II, III)
PRIMARY 
HYPERALGESIA 
(STUDIES I, II, III)
INSIDE
SKIN AND DEEP 
TISSUES
OUTSIDE INSIDE OUTSIDE
INSIDE OUTSIDE
SKIN AND DEEP 
TISSUES
10 
 
4 Introduction 
 
4.1 General Aspects of Pain 
 
According to the International Association for the Study of Pain (IASP), pain is defined as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue damage, or 
described in terms of such damage” (IASP, 1994). Pain comprises a complex experience involving 
not only the transduction of noxious stimuli but also cognitive and emotional aspects of the stimuli 
when it is processed in higher cortical areas in the brain (Basbaum et al., 2009). It is considered a 
personal experience and can only be studied in human beings, the only specie capable of  
communicating emotional and sensory experience (Pedersen 2000). Pain is commonly divided in 
acute and chronic pain. The acute pain, considered as a protective phenomenon, appears quickly 
after tissues injury and disappears gradually by a healing process (Kuner 2010). If the nociceptive 
input persists after healing, a state of chronic pain can develop (Jensen et al., 2003). 
The term nociceptor indicates a sensory receptor that responds to relatively high magnitude or 
potentially noxious stimuli. The nociceptors, thinly myelinated Aδ and unmyelinated C afferents 
(polymodal nociceptors), are peripheral nerve endings located in different tissues of the body 
including skin, connective tissues, blood vessels, viscera and deep somatic tissues like muscles and 
joints. The process of nociception refers to the recognition of a noxious stimulus from a nociceptor 
and its transmission to the brain through peripheral and central neurons (Holdcroft and Jaggar 2005; 
Kidd and Urban 2001; Woolf 1983). Alteration of the pain path induces hyper responsiveness or 
hypersensitivity (Basbaum et al., 2009). Pain hypersensitivity appears in two forms: 
• Hyperalgesia, defined as an “increased response to a stimulus which is normally painful” (IASP, 
1994). 
• Allodynia, defined as “pain due to a stimulus which does not normally provoke pain” (IASP, 
1994). 
After a stimulus, when hyperalgesia and allodynia are both present, the only term that can be used is 
“hyperalgesia” (Lindblom et al., 1986; Pedersen 2000). The term primary hyperalgesia indicates an 
increase in nociceptor responsiveness in the site of injury, while secondary hyperalgesia indicates 
an increase in responsiveness to normal painful stimuli in the undamaged area surrounding the 
injury (Fig 1), (Ali et al., 1996; Meyer et al., 2006). There are two processes contributing to 
hyperalgesia defined as the peripheral sensitization (increased responses of nociceptors located in 
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the peripheral tissues) and sensitization of central mechanisms (increased responses from dorsal 
horn neurons, involving the central nervous system) (Graven-Nielsen and Arendt-Nielsen 2010). In 
sensitization of central mechanisms, the central integrative mechanisms are up-regulated, leading to 
facilitated temporal summation of pain, defined as the progressive intensification in pain perception 
in response to a stimulus sequence having identical intensity (Graven-Nielsen and Arendt-Nielsen 
2010). 
 
 
Figure 1: Schematic representation of allodynia and hyperalgesia. The two curves represent the 
relation between the stimulus intensity and the pain response.  
 
4.2 Inflammatory Pain 
 
The term inflammatory pain indicates the pain originating from a tissue injury, irritation or 
infection, which usually lead to inflammation (Holdcroft and Jaggar 2005). The inflammatory 
process is part of the biological response of the body to a wide range of insults, like pathogens, 
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damaged cells, or irritants (Ferrero-Miliani et al., 2007). This natural “defense” process determines 
hyperalgesia and an increased blood flow in the area, accompanying with an accumulation of fluid 
(edema). The symptoms of inflammation consist of warmth and redness of the skin, along with 
swelling and pain (Holdcroft and Jaggar 2005). Those reactions contribute to prevention of further 
injury and to the resolution of the damage. Inflammatory pain and inflammation are mediated by 
release of inflammatory mediators, called also “inflammatory soup”, from damaged cells that 
increase the sensitivity of nociceptors to noxious thermal or mechanical stimuli (Basbaum et al., 
2009; Holdcroft and Jaggar 2005; Huang et al., 2006). These inflammatory mediators include 
extracellular proteases and protons, arachidonic acid, neurotransmitters, bradykinin, NGF and ATP. 
Among these inflammatory mediators, some substances like protons, ATP and serotonin can act 
directly on the nociceptors by interacting with ion channels or specific receptors located on the 
surface of the sensory nerve endings innervating the area (Basbaum et al., 2009; Julius and 
Basbaum 2001). Other mediators, such as bradykinin and NGF, act by binding to metabotropic 
receptors and membrane receptors that work through a secondary messenger (Julius and Basbaum 
2001). All primary sensory nociceptors make synaptic connections at the level of the spinal cord 
with dorsal horn neurons. These neurons then, transmit pain messages to specific parts of the brain, 
such us thalamus, reticular formation, and cerebral cortex (Julius and Basbaum 2001). Several 
clinical conditions are characterized by the presence of inflammatory reaction, including 
rheumatoid arthritis, a common chronic inflammatory disorder involving the synovial membrane 
and the joints (Choy and Panayi 2001) and fibromyalgia, a disorder of generalized musculoskeletal 
pain (Wolfe 1991). 
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4.3 Experimental pain models of cutaneous inflammation 
 
Human experimental pain models that mimic human clinical pain conditions are valuable tools in 
the study of pain mechanisms and analgesic effectiveness of drugs in early stages of clinical trials 
(Arendt-Nielsen et al., 2007; Ren and Dubner 1999). A pain model to be considered ideal must 
provide a reproducible and standardized condition and a high accuracy of the pain assessments 
(Gustorff et al., 2004a; Sycha et al., 2005). It also has to be simple to perform, without any sign of 
spontaneous pain, and it must cause stable and reproducible primary and secondary hyperalgesia 
without inducing tissue or psychological damages (Petersen and Rowbotham 1999). The most 
important challenge when dealing with human experimental pain models is to evaluate if 
mechanisms seen using experimental pain models can actually reflect the mechanisms seen in 
clinical conditions of pain as inflammatory and musculoskeletal  disorders (Schmelz M. et al., 
2010). 
Cutaneous experimental pain models are the most used ones, mostly because of the easy access to 
the skin (Staahl and Drewes 2004), and a widespread range of inflammatory substances and irritants 
can be used to produce temporary and reversible tissues injury and hyperalgesia in the skin (Zhang 
and Ren 2011). The most important pain models used to induce pain hypersensitivity in cutaneous 
and subcutaneous tissues are burn and freeze injury models, ultraviolet irradiation model (UVB 
model), and capsaicin model. Capsaicin, the component of chili peppers, is one of the most used 
chemically-induced pain models and it causes a type of inflammation called neurogenic 
inflammation (Staahl and Drewes 2004). Several studies have confirmed that capsaicin induces flare 
reaction, hyperalgesia and allodynia in the area of application and in the adjacent area (Bishop et 
al., 2009; Zhang and Ren 2011). Burn and freeze injury models are frequently used in humans to 
induce either primary or secondary hyperalgesia by application of warm (52°C/30-45 s) or cold (-
28°C) stimuli, respectively (Zhang and Ren 2011).  
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4.3.1 Ultraviolet-B Pain Model 
 
Ultraviolet-B (UV-B) irradiation model is a well-known translational model since it has been used 
to induce cutaneous inflammatory pain in both animals (Bishop et al., 2007; Davies et al., 2011) and 
humans (Bishop et al., 2010; Gustorff et al., 2013; Harrison et al., 2004). This model causes an 
erythema called “sunburn” along with thermal and mechanical hyperalgesia (Bishop et al., 2009; 
Gustorff et al., 2013). In this PhD project, the UVB inflammatory pain model was used to induce 
inflammation, allodynia and hyperalgesia in human skin. These reactions are present in a variety of 
chronic inflammatory states, such as rheumatoid arthritis, and can be used in healthy volunteers to 
study the pain system under well controlled settings (Handwerker and Arendt-Nielsen 2013; Staahl 
and Drewes 2004). The UVB model has been chosen since it is a stable and reproducible model that 
has been extensively investigated both in animals and humans and does not cause spontaneous pain 
or tissues damage (Bishop et al., 2009; Davies et al., 2011; Gustorff et al., 2004b; Gustorff et al., 
2013). Moreover, the UVB model is able to induce a long-lasting hyperalgesic reaction in 
comparison to other models such as capsaicin-induced inflammation (Pitcher et al., 2008; Sycha et 
al., 2003).  
Humans are normally exposed to UVB radiation through natural sunlight but there are also artificial 
sources of UVB radiation such as sun-beds, phototherapy lamps or tungsten-halogen lamps 
(Honigsmann 2002). In this PhD project, UVB irradiation was applied using a calibrated UVB 
source (wavelength 290-320nm; Saalmann Multitester, Saalmann, SBC LT 400 Herford, Germany) 
on different skin sites. The skin was irradiated by using UVB dose of 3 times the individual MED 
(calculated for each test person). The individual minimal erythematic dose (MED) is known as the 
minimum amount of UVB energy (J/cm2) that 24 h after exposure produces an erythematic area 
with distinct borders.  
Ultraviolet-B (UV-B) ranging from 290 to 320 nm is a component of sunlight and can be 
considered the most effective in inducing the cutaneous sunburn reaction (Benrath et al., 2001). 
This reaction is generally classified as a superficial or first-degree burn (McStay ; Soter 1990), and 
is considered an acute inflammatory reaction caused by an excessive exposure of the epidermis to 
UVB radiations (Honigsmann 2002). The UVB-irradiation is mostly absorbed by the chromophores 
present in the epidermis and leads to destruction of epidermal cells, like keratinocytes and to release 
of numerous cytokines and inflammatory mediators into the skin (Honigsmann 2002). A large 
number of these mediators such as nitric oxide, histamine, bradykinin, prostaglandins, cytokines, 
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and NGF are involved in the sensitization of the peripheral nociceptors located on the sensory 
neurons innervating the region of the irradiation (Dray 1995; Kidd and Urban 2001). Skin 
inflammation produced by UVB induces an erythema called “sunburn” accompanied by thermal 
and mechanical hyperalgesia and changes in tissues perfusion in the area of irradiation (area of 
primary hyperalgesia) and in the adjacent areas (area of secondary hyperalgesia) (Gustorff et al., 
2004a; Gustorff et al., 2004b; Sycha et al., 2005) (Fig 2). These characteristics of the UVB model 
peak 24 h after irradiation and have been demonstrated in men and rodents (Bishop et al., 2009; 
Davies et al., 2011; Gustorff et al., 2013). UVB irradiation also induces increased pigmentation and 
thickening of the epidermis (Honigsmann 2002). Several studies have concluded that the decrease 
in thermal pain threshold induced by the UVB-model is transmitted through unmyelinated C-fibres, 
whereas the decrease in mechanical pain thresholds is transmitted through myelinated Aβ and Aδ 
fibres (Bishop et al., 2009; Gustorff et al., 2004a; Sycha et al., 2005). An overview of the human 
studies conducted on the UVB-pain model is shown in Table 1. In general, all the studies presented 
in the table concluded that UVB-irradiation induced both thermal and mechanical hyperalgesia in 
the area of irradiation but presented controversial results regarding the existence of secondary 
hyperalgesia. 
In addition to studying pain mechanisms and pathways, the UVB model can also be considered a 
valid tool for testing or screening of analgesic drugs. Recently, this model has been used to test the 
efficacy of opioids, morphine and remifentanil (Gustorff et al., 2004b; Koppert et al., 2004; Staahl 
et al., 2009) and non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and rofecoxib (Bickel 
et al., 1998; Sycha et al., 2005; Sycha et al., 2003). Table 2 shows an overview of all the human 
studies investigating the effect of drugs via the UVB model. All these studies confirmed that the 
UVB pain model can be used as a valid tool for screening different analgesic drugs. The papers 
presented in the tables have mostly been selected through the databases PubMed and Medline using 
the following search strings: UVB and hyperalgesia; time course of UVB-induced inflammation, 
UVB and pain. 
Even though the UVB model has been well characterized both in animals and humans (Bishop et 
al., 2009; Bishop et al., 2007; Davies et al., 2011; Gustorff et al., 2013; Harrison et al., 2004), the 
presence of secondary hyperalgesia in this model is still controversial. For this reason, in this PhD 
project one of the aims was to study the alteration in cutaneous vaso-response, mechanical and 
pressure pain sensitivity within and outside the UVB-irradiated area and a possible convergence 
between inputs coming from the irradiated skin and the underling deep somatic area. 
16 
 
What is also still unknown is the possibility of an interaction between superficial and deep 
inflammatory models, when those are applied in combination, even though the existence of 
convergence between afferent nociceptive fibres from superficial and deep structures has been 
demonstrated (Hoheisel and Mense 1990; Yu and Mense 1990). Based on this evidence, this PhD 
study also evaluated whether intramuscular sensitization may affects the UVB-induced cutaneous 
hyperalgesia when combining it with the UVB inflammatory model. 
 
                                    
 
Figure 2: Image of upper arm irradiated with 3xMED after removal of the EMLA cream. Data 
taken from Study III. 
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Author 
and Year 
Title Aim Tests 
performed 
Results 
regarding 
primary 
hyperalgesia 
Results 
regarding 
secondary 
hyperalgesia 
Conclusion 
Hoffman 
and 
Schmelz 
(1999) 
Time course of 
UVA- and UVB-
induced 
inflammation 
and hyperalgesia 
in human skin 
To evaluate 
dose–response 
and time  course 
of inflammation 
and hyperalgesia 
following UVA 
and UVB  
irradiation. 
HPPT, 
mechanical 
hyperalgesia 
(assessed using 
impact 
stimulation). 
Only UVB 
Irradiation 
induced HPPT 
decrease and 
mechanical 
hyperalgesia 
Not reported UVB- but not UVA- 
irradiation can be used as  
experimental model to 
induce both thermal and 
mechanical hyperalgesia. 
Gustorff 
and 
colleagues 
(2004) 
The sunburn 
pain model: the 
stability of 
primary and 
secondary 
hyperalgesia over 10 
hours in a crossover 
setting 
To investigate 
repeatability and 
stability  
of PH and SH 
over 10 h. 
HPTT, area of 
SH (assessed 
using 150 g von 
Frey), Electrical 
Pain 
Tolerance 
Thresholds (5 
Hz & 250 Hz). 
Decrease of 
HPTT. 
Decrease of 
Electrical 
PTT at 250 Hz. 
Pin-prick SH 
present. No 
SH to HPTT. 
No SH to 
Electrical PTT 
The UVB model presents 
both high within-day 
stability and between-day 
repeatability for both PH 
and SH. UVB-induced SH 
has been demonstrated for 
the first time in this study. 
Bishop and 
colleagues 
(2009) 
Ultraviolet-B 
induced 
inflammation of 
human skin: 
Characterisation 
and comparison 
with traditional 
models of 
hyperalgesia 
To investigate the  
dose dependence 
and  time course  
of  UVB 
inflammation.  
 
Mechanical 
hyperalgesia 
(assessed by 10 
g von Frey), 
HPPT, allodynia 
(assessed using 
brush). 
 
The mechanical 
hyperalgesia 
was present and 
HPPT 
decreased. 
 
No allodynia 
or 
hyperalgesia 
were present. 
The UVB model produces 
changes in sensory 
processing within the area 
of PH with only minimal 
changes in the area of SH. 
Gustorff 
and 
colleagues 
(2013) 
The pattern and 
temporal profile of 
somatosensory 
changes in the 
human UVB 
sunburn model 
reveal the presence 
of peripheral and 
central sensitization 
To characterize 
time course and 
magnitude of 
sensory changes 
evoked by UVB 
irradiation in both 
primary and 
secondary 
hyperalgetic 
areas. 
HPPT, CPT, 
PPT, MPT, 
DMA, 
mechanical pain 
sensitivity 
CPT increased, 
HPPT, MPT 
and PPT 
decreased. 
DMA, MPT 
decreased 
The UVB model induced 
primary hyperalgesia 
accompanied by a moderate 
degree of secondary 
hyperalgesia. 
Weinkauf 
and 
colleagues 
(2013) 
Modality-specific 
nociceptor 
sensitization 
following UV-B 
irradiation of human 
skin 
To study if UVB 
irradiation may 
increase the 
axonal excitability 
of nociceptors. 
Mechanical 
impact stimuli, 
MPT, PPT, 
electrical pain 
thresholds, 
HPPT 
HPPT, MPT, 
PPT, 
mechanical 
impact stimuli 
and electrical 
pain thresholds 
decreased.  
Not reported UVB irradiation induced 
increased axonal 
excitability. 
Mørch and 
colleagues 
(2013) 
The UVB cutaneous 
inflammatory pain 
model: a 
reproducibility study 
in healthy volunteers 
To study  the test-
retest reliability of 
the UVB 
inflammatory 
model. 
DMA (brush), 
tactile 
perception 
threshold 
(assessed using 
von Frey), PPT, 
HPPT, SH 
DMA, PPT and 
HPPT decreased 
SH was 
present 
UVB model induced 
neurogenic inflammation 
and hyperalgesia with 
highly reproducibility 
within and between 
sessions. 
 
Table 1. Overview of human studies using the UVB model. 
Abbreviations used: HPR = heat pain response, HPPT = heat pain perception threshold, HPTT = 
heat pain tolerance threshold, CPT= cold pain threshold, PPT= pressure pain threshold, MPT= 
mechanical pain threshold, DMA= dynamic mechanical allodynia, WPT= warmth perception 
threshold, PH = primary hyperalgesia, SH = secondary hyperalgesia.  
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Author 
and Year 
Title Aim Drug tested Tests 
performed 
Results 
regarding 
primary 
hyperalgesia 
Results 
regarding 
secondary 
hyperalgesia 
Conclusion 
Bickel and 
colleagues 
(1998) 
Effects of anti-
hyperalgesic 
drugs on 
experimentally 
induced 
hyperalgesia in 
man 
To compare 
the anti-
hyperalgesic 
effects of 
Ibuprofen on 
PH. 
Ibuprofen HPPT, 
mechanical 
hyperalgesia 
(assessed using 
impact of 5, 9, 
and 13 m/s), 
repetitive 
pinching. 
3xMED: UVB 
induced both 
heat 
hyperalgesia 
and 
mechanical 
hyperalgesia 
for 9 and 13 
m/s. 
Not reported Ibuprofen had an 
analgesic 
effect on both thermal and 
mechanical PH. The k-
agonist did not showed 
any effect on UVB 
irradiation. 
Koppert 
and 
colleagues 
(1999) 
Peripheral 
antihyper- 
algesic effect of 
morphine to 
heat, but not 
mechanical, 
stimulation in 
healthy 
volunteers after 
ultraviolet-B 
irradiation 
To study the 
peripheral 
effects of 
Morphine. 
Morphine Mechanical 
hyperalgesia 
(assessed using 
impact stimuli) 
and  HPPT. 
Morphine 
reduce heat 
hyperalgesia 
but showed 
no effect on 
mechanical 
hyperalgesia. 
Not reported The antihyperalgesic 
effect of morphine was 
present in the irradiated 
area. 
Sycha and 
colleagues 
(2003) 
A simple pain 
model for the 
evaluation of 
analgesic effects 
of NSAIDs in 
healthy subjects 
To evaluate 
the 
effectiveness 
of UVB 
model in 
testing 
NSAIDs 
Ibuprofen HPPT, HPTT Ibuprofen 
increased both 
HPPT and 
HPTT. 
Not reported The effect of ibuprofen 
was significant and the 
UVB model is a valid tool 
for testing NSAIDs 
Gustorff 
and 
colleagues 
(2004) 
The Effects of 
Remifentanil and 
Gabapentin on 
Hyperalgesia in 
a new 
extended 
inflammatory 
skin 
pain model in 
healthy 
volunteers 
To test the 
effect of two 
different 
drugs alone 
and in  
combination. 
Remifentani
l and 
Gabapentin 
HPTT, HPPT, 
area of SH 
(assessed using 
150 g von Frey), 
 
Decreased of 
both HPTT 
and HPPT. 
Remifentanil 
increased both 
HPPT and 
HPTT in the 
area of PH 
and in the 
normal skin. 
Remifentanil 
reduced SH. 
Gapapentin; 
no reduction. 
Opioid analgesia was 
demonstrated in 
the UVB model of PH 
and SH. 
Sycha and 
Colleagues 
(2005) 
Rofecoxib 
attenuates both 
primary and 
secondary 
inflammatory 
hyperalgesia: a 
randomized, 
double blinded, 
placebo 
controlled 
crossover 
trial in the UVB 
pain model 
To study 
the effects of 
rofecoxib on 
PH and SH 
induced by 
UVB 
irradiation. 
Rofecoxib HPTT, HPPT 
and area of SH 
(assessed using 
150 g von Frey), 
 
Rofecoxib 
increased both 
HPTT and 
HPPT. 
Rofecoxib 
reduced SH. 
Rofecoxib induced 
peripheral effects and 
reduced SH in 
inflammatory pain. 
Eisenach 
and 
colleagues 
(2010) 
Effects of 
Intrathecal 
Ketorolac on 
Human 
Experimental 
Pain 
To assess the 
role of spinal 
Cyclo-
oxygenase on 
hyper-
sensitivity. 
Ketorolac Allodynia (to 
stroking) and 
mechanical 
hyperalgesia 
(assessed using 
225 mN von 
Frey) 
 
Small areas of 
Hyperalgesia 
and allodynia 
unaffected by 
ketorolac. 
 
Areas of SH  
unaffected by 
ketorolac. 
Allodynia not 
present. 
 
Intrathecal ketorolac 
reduced the area of 
allodynia after UVB but 
showed no effect on pain 
raising from acute heat 
stimuli or capsaicin. 
Ortner and Dose response of To determine Tramadol HPPT, CPT, Tramadol but Both In inflammatory 
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colleagues 
(2011) 
tramadol and its 
combination 
with paracetamol 
in UVB induced 
hyperalgesia 
tramadol and 
tramaldol + 
paracetamol 
effect on 
primary and 
secondary 
hyperalgesia. 
and 
Paracetamol 
mechanical 
hyperalgesia 
and allodynia 
(assessed using 
256 mN pin-
prick), DMA 
not 
paracetamol 
decreased 
CPT and 
mechanical 
hyperalgesia 
Tramadol and 
Paracetamol 
reduced SH. 
hyperalgesia tramadol 
exerts a weak anti-
hyperalgesia. Adding a 
small dose of paracetamol 
enhances thermal anti-
hyperalgesia. 
Rössler and 
colleagues 
(2013) 
Central origin of 
pinprick 
hyperalgesia 
adjacent to an 
UV-B induced 
inflammatory 
skin pain model 
in healthy 
volunteers 
To evaluate if 
SH can be 
reduced by 
superficial 
local 
anaesthetic 
Lidocaine Mechanical 
hyperalgesia 
(assessed using 
256 mN pin-
prick) and 
allodynia (to 
stroking), 
HPPT, CPT, 
PPT, WPT. 
Presence of 
area of 
hyperalgesia 
and allodynia. 
All the 
measurements 
were not 
affected by 
the lidocaine 
perfusion. 
Hyperalgesia 
and allodynia 
were not 
affected by 
the 
anaesthetic 
block. 
Mechanical hyperalgesia 
was unchanged after 
application of anaesthetic 
8 h after irradiation 
confirming the presence 
of central mechanism 
mediating secondary 
hyperalgesia. 
 
Table 2. Overview of human studies testing drugs in the UVB model 
Abbreviations used: HPR = heat pain response, HPPT = heat pain perception threshold, HPTT = 
heat pain tolerance threshold, CPT= cold pain threshold, PPT= pressure pain threshold, DMA= 
dynamic mechanical allodynia, WPT= warmth perception threshold, PH = primary hyperalgesia, 
SH = secondary hyperalgesia.  
 
4.4 Deep-Tissues Pain Models 
 
Several different methods can be used to induce experimental pain for the quantitative assessment 
of the pain sensitivity in deep tissue. These methods can be divided in two major categories: the 
exogenous models are methods involving external stimuli (such as pressure stimulation or injection 
of algesic substances like NGF or saline injections), whereas the endogenous methods are methods 
inducing pain in deep-tissue by physiological stimuli such as eccentric exercise (Graven-Nielsen 
and Arendt-Nielsen 2010). The muscle nociceptors are free nerve ending nociceptor and are divided 
in group III, corresponding to the cutaneous Aδ-fibres, and group IV, corresponding to the 
cutaneous C-fibres.  
 In this PhD project, in order to investigate the effect of a possible convergence between cutaneous 
(the UVB cutaneous pain model) and deep-tissue hyperalgesia, the delayed onset muscle soreness 
(DOMS) pain model was applied. In addition, the NGF model was used in association with the 
UVB model in order to investigate whether the combination between cutaneous and muscle 
hyperalgesia may influence the responsiveness of the UVB model. Both DOMS and NGF pain 
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models are well established models to induce deep-tissue hyperalgesia (Andersen et al., 2008; 
Gibson 2007). 
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4.4.1 Exercises-induced Delayed Onset Muscle Soreness Model 
 
Eccentric exercise is an endogenous method to evoke experimental deep tissue pain commonly used 
to induce muscle hyperalgesia (Gibson 2007). The eccentric activity is characterized by elongation 
of muscle during simultaneous contraction. When the external load outdoes the ability of the muscle 
to resist the load, the muscle is forced to lengthen, producing an active tension (Nie et al., 2007; 
Stauber 1989). Eccentric exercise induces delayed onset muscle soreness (DOMS) that occurs as a 
result of changes in the muscle fibres within 24 and 48 hours after eccentric exercise (Armstrong 
1984) and manifests as aching pain accompanied by tenderness and stiffness (Dannecker et al., 
2003). Those sensations usually diminish within 5–7 days after the exercise (Nie et al., 2005). The 
exercises-induced DOMS is a well-established and long-lasting model and resembles some 
characteristics seen in several clinical conditions in musculoskeletal pain or ischemic muscle pain 
(Handwerker and Arendt-Nielsen 2013; Nie et al., 2005). DOMS has been investigated in both 
humans and animals (Cheung et al., 2003; Murase et al., 2010; Taguchi et al., 2005), and the 
research results reflect events seen in acute inflammation (Smith 1991). To explain the development 
of DOMS, different mechanisms have been proposed based on biochemical, ultrastuctural and 
histological studies conducted both in animals and humans (Murase et al., 2010). One of the most 
supported mechanisms is based on the existence of minor muscle traumas causing an increased 
release of inflammatory substances (bradykinin, histamine, prostaglandins, glutamate and 
neutrophils) as a consequence of the inflammatory response. This has been confirmed by MacIntyre 
and co-workers who found a great presence of neutrophils in the eccentric-exercised muscle tissue 
compared to the non-exercised muscle for up to 4 h post-exercise as a consequence of the increased 
blood circulation in the muscle after eccentric activity (MacIntyre et al., 2000; Nosaka and Clarkson 
1996). Due to the inflammatory process, DOMS has been attributed to peripheral sensitization but 
central mechanisms may also be involved since facilitated temporal summation to repetitive 
pressure stimulations during DOMS has been demonstrated (Nie et al., 2006). Another important 
theory considers NGF as the key substance in maintaining DOMS induced by eccentric contraction 
(Murase et al., 2010). In experiments conducted in rats, Murase and co-workers demonstrated that 
intramuscular administration of anti-NGF antibody 6 h after eccentric contractions could block 
completely the induction of muscle mechanical hyperalgesia (Murase et al., 2010). Murase’s 
experiment also confirmed a 12 h delay of the NGF mRNA up-regulation after eccentric activity 
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that may explain the delayed development of DOMS following eccentric contraction, which is in 
line with similar reports in humans (Murase et al., 2010). 
DOMS is usually induced in the muscles of arm and leg (Nie et al., 2005) but is not commonly 
induced in the lumbar muscles, even though low back is often involved in clinical pain conditions. 
In this PhD project, DOMS in the lumbar extensors was induced by asking subjects to perform 50 
back exercises (eccentric contraction of the lumbar muscles, Fig 3).  
 
 
 
Figure 3: Schematic representation of the eccentric contraction of the lumbar muscles performed 
by the subjects. 
 
The exercises-induced DOMS model presents several limitations. Based on the Likert scale results 
(Study II) it can be assumed that this model does not induce an equal level of muscle soreness and 
hyperalgesia in all individuals undergoing this procedure. This is probably due to gender difference 
(MacIntyre et al., 2000) or differences in muscle training among the subjects. Furthermore, DOMS 
does not induce pain at rest, typically present in musculoskeletal conditions such as fibromyalgia 
(Gracely et al., 2003),  and has also the disadvantage of being difficult to control since this method 
involves numerous muscle groups within the investigated region (Staahl and Drewes 2004).  
This study is the first to assess the possibility of an interaction between superficial and deep 
sensitization utilizing established models of skin and muscle hyperalgesia. Moreover, the DOMS 
model has been chosen since it peaks around 24 h post-exercises similar to peak of the effects in 
response to UVB model in the skin. This will allow a better evaluation of the pain changes induced 
by both methodologies applied in combination.  
  
23 
 
4.4.2 Nerve Growth Factor Pain Model 
 
Several studies have shown that muscular hyperalgesia can be experimentally induced by 
application of various substances into the muscles. This sensitization mimics the inflammatory 
condition and the decrease in pain thresholds present in some disorders involving the 
musculoskeletal system, making the models very useful from a clinical perspective (Mørk et al., 
2003; Staahl and Drewes 2004). The nerve growth factor (NGF) is a molecule member of a family 
of peptides called neurotrophins and plays a key role in the development of the peripheral nervous 
system and in the inhibition of programmed cell death in neurons in the peripheral nervous system 
(Frade and Barde 1998; Rueff and L.M. 1996). NGF is normally secreted from various tissues, 
including muscles and can bind to neurons expressing the trkA receptor (Andersen et al., 2008; 
Rueff and L.M. 1996). The role of NGF in the inflammation has been investigated by several 
groups (Donnerer et al., 1992; Rueff and L.M. 1996; Woolf et al., 1994). As a direct consequence of 
the inflammatory process, the NGF production increases in the periphery and, in case of persistent 
inflammation, it can be transported backward from the periphery toward the dorsal root ganglion 
(Goedert et al., 1981; Lewin and Mendell 1993). The increased concentration of NGF in the skin 
during inflammation is due to its release from keratinocytes that can be induced by tumor necrosis 
factor alpha (TNFα) and interleukins (IL-1β), which are released from mast cell and macrophages 
during inflammation (Lindholm et al., 1987; Rueff and L.M. 1996). It has also been demonstrated 
that the exposure of nociceptors to NGF increases the release of the neuropeptides such as 
substance P and calcitonin gene-related peptide (CGRP), both related to the development of pain 
and hyperalgesia (Greco et al., 2008; Rueff and L.M. 1996; Woolf et al., 1994). A confirmation of 
the direct role of NGF in hyperalgesia emerged from studies applying NGF injections in both 
animals and humans. Systematic injections of NGF into rats cause hypersensitivity to noxious heat 
and mechanical stimuli that persists for days (Frade and Barde 1998). Moreover, intramuscular 
injection of NGF in the tibialis anterior muscle in healthy volunteers induced mechanical 
hyperalgesia one day after the injection, lasting up to 7 days after the administration (Andersen et 
al., 2008). A large number of studies have also investigated the possibility of reversing 
inflammatory pain by blocking the action of NGF using anti-NGF antibodies or similar agents able 
to bind free molecules of NGF (Frade and Barde 1998; Rueff and L.M. 1996; Woolf et al., 1994). 
All studies confirm that inflammatory hyperalgesia was reduced by blocking NGF, confirming that 
the release of NGF is necessary to produce a hyperalgesic reaction. Several disorders, including 
arthritis and cystitis, have also been shown to include the inflammatory process associated with 
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increased NGF release (Hudspith et al., 2006). The direct relationship among inflammation, NGF, 
and the long-lasting muscle hyperalgesia induced by this model are the principal reasons explaining 
the selection of this model in this PhD project to investigate if NGF-muscle sensitization of the 
muscle below the UVB-irradiated area can modify the responsiveness of UVB-irradiated skin to 
heat rekindling of the UVB area. Moreover, this is a completely different model from the DOMS 
model since it is a chemical model. 
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5 General methodological approaches 
5.1 Assessment of Vasomotor Response 
 
Inflammatory process and its associated changes are usually reflected in the skin, where it is also 
possible to assess cutaneous blood flow changes. These have been investigated in several areas of 
medicine, such as dermatology, plastic surgery, and vascular medicine (Clauw et al., 2011; Essex 
and Byrne 1991). The cutaneous microcirculation includes two different horizontal plexuses. The 
first is located 1-1.5 mm under the surface of the skin, whereas the second one is located at the 
intersection between the dermis and the subcutaneous tissue (Braverman 2000; Clough and Church 
2002). A wide range of techniques can be used to measure the cutaneous blood flow, such 
thermography, a technique allowing a continuous monitoring of the skin temperature (Jasemian et 
al., 2012), ultrasound, laser-Doppler flowmetry, allowing measurement of microvascular tissue 
perfusion based on the Doppler effect (Wardell et al., 1993), and laser-Doppler imaging (Clough 
and Church 2002). Among these different methodologies, the laser-Doppler imaging technique 
(LDI) is considered one of the best validated techniques for use in a clinical experiments (Clough 
and Church 2002) and was employed in this PhD project as described below. 
 
5.1.1 Laser Doppler Imaging 
 
The LDI scanner is a device that measures the cutaneous blood flow by using a mirror deflecting 
laser beam onto the skin surface. A 2 mW, 633-nm, red helium-neon laser scans the surface of the 
skin, and light, back-scattered from moving red blood cells, is shifted in frequency according to the 
Doppler principle and the flux is expressed in arbitrary unit (AU) (Newton et al., 2001). The 
erythrocytes velocity is then calculated and represents a relative measure of cutaneous blood flow 
(Gustorff et al., 2013). At the end of the measurement, the instrument produces a color two-
dimensional image representing the erythrocytes flux up to a depth of ~0.6-1 mm (Clough and 
Church 2002). In this PhD project, the alteration in blood perfusion following an inflammatory 
process in the skin and deep-tissues was quantified by the laser Doppler imaging technique (Moor 
Laser Doppler Imager V3.08, Moor Instruments Ltd, Devon, UK). The laser head was always 
positioned at a fixed distance of 30 cm above the irradiated skin, with the laser beam perpendicular 
to the skin and the scan was performed with a 256 x 256 pixel resolution. The measurement was 
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performed in a temperature-controlled room, with the subject resting in a bed. Prior to and during 
the study sessions, the use of any substance (caffeine, nicotine, alcohol) that could influence the 
blood flow measurements was prohibited. Several studies have shown that nicotine and alcohol 
intake can induce changes in cutaneous blood flow (Waeber et al., 1984; Wilkin and Fortner 1985).  
Among these different methodologies, the laser-Doppler imaging technique (LDI) was employed in 
the PhD project since it allows remote skin blood flow measurements without any skin contact 
(Clough and Church 2002), avoiding changes of the results due to skin manipulation in the inflamed 
area. Another reason for choosing this methodology is that the LDI permits measurement of a large 
area of the skin allowing seeing the changes in blood flow inside and outside the irradiated areas in 
a single measurement. 
 
5.2 Assessment of Mechanical Pain Sensitivity 
 
The mechanical pain thresholds (MPT) in the skin were determined using weight-calibrated pin-
prick stimulators (Aalborg University, Denmark). This is a set of weight-calibrated metal probes 
that are used to determine the area of secondary hyperalgesia (Staahl and Drewes 2004). Pinprick 
stimulation seems to activate mostly Aδ-fibres and the feeling is reported as pricking or ‘‘first 
pain’’(Staahl and Drewes 2004). The pin-prick stimulators have a metal probe with a diameter tip of 
0.6 mm and different weights and the MPT is defined as the lightest pin-prick stimulator that can 
induce a sharp sensation. The pin-prick stimulator represents a rapid sensory assessment for the 
estimation of MPT and is simple to perform. In order to produce a constant evaluation of MPT, the 
test should always be performed by the same investigator. Moreover, the pin-prick stimulator 
should be pressed gently against the skin so that the pin-prick sensation is only caused by the 
applied force and based on the calibrated weight of the stimulator (Chan et al., 1992). Since the 
stimulation induced by the pin-prick stimulator may last for a few seconds, it is also very important 
to apply the successive stimulation with a reasonable gap time when it is applied repeatedly (Chan 
et al., 1992). 
The von Frey hair stimulator is a tool used to determine touch perception thresholds 
(Aesthesiometer, Somedic AB, Hörby, Sweden) and consists of a set of 19 filaments having 
different diameter mounted on plexiglas handles. In this project only the 26 g stimulator has been 
used to map the allodynic area after UVB irradiation or after heat rekindling since it corresponds to 
a light touch and is not painful in normal skin. When the applied stimulation reaches a certain 
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pressure, the filament bends, allowing the activation of Aβ-fiber mediating touch sensation and the 
measurement of the allodynic area (Staahl and Drewes 2004). 
In this project two different approaches were used to map the areas of hyperalgesia and allodynia. 
For mapping the hyperalgesic area, the pin prick corresponding to the MPT of the subjects was 
used, whereas a single von Frey hair stimulator (26 g) has been used for mapping the allodynic area. 
 
5.3 Heat Rekindling Protocol 
 
The heat rekindling is a technique based on the application of mild heat stimuli to enhance afferent 
input from an already established sensitization. The concept behind the heat rekindling is that the 
heat stimulation sustains and enhances the initial response of the applied hyperalgesic model 
(Eisenach et al., 2010). Heat rekindling has been initially applied in combination with the capsaicin 
pain model. A mild and non-painful heat stimulus of 40°C for 5 minutes was applied resulting in a 
reinforcement of the secondary hyperalgesic area for up to 4 h (Petersen and Rowbotham 1999). 
Recently, the heat rekindling has been used in combination with the UVB-inflammatory pain model 
in order to enhance the effect of the UVB irradiation on the area of secondary allodynia and 
hyperalgesia (Cookson et al., 2005; Davies et al., 2011; Eisenach et al., 2010). In their recent study, 
Eisenach and collaborators, demostrated that heat rekindling performed after cutaneous UVB 
irradiation induced a larger area of secondary hyperalgesia compared to UVB alone (Eisenach et al., 
2010). Several studies have also used the heat/UVB model to test the efficacy of a wide range of 
drugs. In a recent study conducted by Wang and co-workers, the UVB/heat pain model has been 
used to test the efficacy of two different drugs: rofecoxib, a cyclooxigenase-2 (Cox-2) inhibitor, and 
ketamine, a N-Methyl-D-aspartate (NMDA) receptor antagonist (Wang et al., 2005). The results of 
this study confirm that the UVB/heat model can be used to test the effects of analgesic drugs 
targeting different receptors. Table 3 shows an overview of the human studies that have investigated 
the UVB/heat model as a pain model and for drug studies.  
In this PhD project, heat rekindling was performed on the skin by a thermod stimulator attached 
precisely on the irradiated area. Two consecutive cycles of rekindling have been performed using 
the same paradigm indicated in the heat/capsaicin model. In order to investigate whether heat 
rekindling could prolong or enhance the secondary area of hyperalgesia and allodynia induced by 
UVB-irradiation, the rekindling was performed 72 h after irradiation, when the hyperalgesic effect 
of UVB started to decrease. 
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Author 
and Year 
Title Aim Tests performed Results  
 
Drug tested Conclusion 
Wang and 
Colleagues 
(2005) 
Antihyperalgesic 
profiles of rofecoxib 
and ketamine in a 
new healthy 
volunteer model of 
inflammatory pain  
To explore 
peripheral and 
central aspects of 
the UVB/heat 
model.  
Laser Doppler 
imaging, PH, SH 
and allodynia.  
Rofecoxib 
reduces PH and 
SH whereas 
Ketamine only 
reduces SH. 
Rofecoxib 
and 
Ketamine 
The UVB/heat model can 
be used to test drugs with 
different mechanism of 
action. 
Cookson 
and 
Colleagues 
(2005) 
A new human 
model of 
inflammatory pain 
and sensitization 
evoked by 
ultraviolet (UV)-
irradiation 
combined with heat 
rekindling 
To enhance the 
central 
mechanism 
involved in the 
UVB model by 
combining UVB 
and heat.  
Flare, HPPT, 
MPT  
UVB-irradiation 
induces flare 
and a decrease 
of both HPPT 
and MPT. 
Increase of SH 
after heat 
rekindling 
None UVB irradiation induced 
primary and secondary 
hyperalgesia that can be 
enhanced by heat 
rekindling.  
Eisenach 
and 
Colleagues 
(2010) 
Effects of 
intrathecal ketorolac 
on human 
experimental pain 
To investigate 
the role of spinal 
cyclooxygenase in 
human by 
injection of 
cyclooxygenase 
inhibitor 
ketorolac. 
Areas of 
hyperalgesia and 
allodynia, 
peripheral 
oxyhemoglobin 
saturation, blood 
pressure and heart 
rate 
Heat rekindling 
increased the 
UVB 
hyperalgesic 
area 
Ketorolac Ketorolac reduced 
hypersensitivity induced by 
UVB alone and UVB plus 
heat. 
 
 
Table 3. Overview of human studies using the Heat/UVB model. 
Abbreviations used: HPR = heat pain response, HPPT = heat pain perception threshold, HPTT = 
heat pain tolerance threshold, MPT= mechanical pain threshold, PH = primary hyperalgesia, SH = 
secondary hyperalgesia. 
 
5.4 Assessment of Pressure Pain Sensitivity  
 
Pressure algometry is one of the most frequently used techniques for the quantification of 
mechanical sensitivity and pain. This method, involving pressure stimulation to induce pain from 
deep structures, can be considered an experimental equivalent to palpation in the clinical practice 
(Graven-Nielsen and Sergerdahl 2001) and has been used extensively (Jensen et al., 1986). It is 
believed that both Aδ- and C-fibres are involved in the perception of the pain arising from pressure 
stimulation (Staahl and Drewes 2004). 
Manual pressure algometry has been used for evaluation of sensitivity to pain and the assessment of 
pressure perception but this methodology has a certain amount of variability, even though  it is 
considered a very reliable method for measuring pressure pain thresholds (Fischer 1987; Potter et 
al., 2006; Reeves et al., 1986). Recently, in order to ensure delivering of consistent pressure during 
the assessments, the computer-controlled algometer (Fig 4A) has been used to evaluate pressure 
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pain sensitivity in different structures (Finocchietti et al., 2011). This methodology, by reducing the 
variability of the measurements, allows an accurate construction of the stimulus-response function, 
a curve relating graded pressure stimulations and pain intensity (Graven-Nielsen et al., 2004). 
Pressure stimulation is applied perpendicularly to the skin surface where the pressure pain threshold 
(PPT) and the pressure pain tolerance (PPTO) can be easily measured. PPT is defined as the point at 
which a feeling of pressure changes into a feeling of pain. PPTO is defined as the greatest pain 
which the subject can tolerate (Finocchietti et al., 2011). The subject presses a push button twice: on 
the first push, the PPT is recorded, and on the second push the PPTO is registered and the 
stimulation is stopped. Additionally, the subject rates the pain intensity continuously during the 
pressure stimulation on an electronic visual analogue scale (VAS 0-10 cm) where 0 indicated ”no 
pain”, and 10 indicated ”maximal pain” (Graven-Nielsen et al., 2004). The pressure vs. VAS 
function can be extracted to allow establishing how this curve can be modulated in response to pain 
and inflammation (Fig 1). Several studies have investigated the effects of cutaneous sensitization on 
pressure pain sensitivity. Among these studies, Gustorff and co-workers and Weinkauf and 
collaborators have concluded that UVB irradiation induced a decrease of PPT assessed using a 
handheld algometer (Gustorff et al., 2013; Weinkauf et al., 2013). Numerous studies, have also 
investigated the effect of deep-tissues sensitization on pressure pain sensitivity. Some of these 
studies using different pain models, reported that deep-tissues sensitization also induced a decrease 
of PPT (Binderup et al., 2010; Jensen and Norup 1992; Nie et al., 2009b). 
The major limitation related to this technique is that the pressure algometry is non-specific since 
both receptors in the skin and in deeper structure can be activated at the same time by the pressure 
stimulation itself (Staahl and Drewes 2004). In order to minimize the effect of the shear strains on 
the skin, the probes are usually covered with a rubber disc so that the cutaneous nociceptor 
activation can be reduced. 
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Figure 4. (A) The computer-controlled pressure algometer. (B) The four different probes used in 
the experiments.   
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6 Main findings 
 
6.1 Cutaneous Blood Flow (BF) 
 
In this project, the development of the inflammatory response in the skin following the application 
of the two different pain models was validated by laser Doppler imaging. In the first experiment, the 
change in cutaneous blood flow was validated after UVB irradiation of the skin, in the area of 
primary and secondary hyperalgesia (Fig 5). 
 
 
 
Figure 5. Images of cutaneous blood flow before (panel A) and after (panel B) UVD irradiation in 
the forearm of one subject. Data are taken from Study I. 
 
Several studies have evaluated the change in blow flow following UVB irradiation. In previous 
studies, it was found that UVB irradiation induces an increase in cutaneous blood flow in the area of 
primary hyperalgesia, but conflicting results were found regarding the increase of blood flow in the 
area of secondary hyperalgesia (Benrath et al., 2001; Bishop et al., 2009). Bishop and collaborators 
(2009) reported increased BF in the area of irradiation but no observable vascular reactions in the 
area surrounding the UVB-irradiated site, whereas Benrath et al. (2001) found, in the forearm of 
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healthy volunteers a 10-fold increase in BF in the inflamed skin and a significant increase up to 1cm 
outside the irradiated area. In line with the findings from Benrath et al, in the first study of this PhD 
project an increase of 8-fold from baseline skin blood flow was found both in the arm and in the 
back and also a small but significant increase in skin blood flow up to 1.5 cm outside the irradiated 
area (Fig 6). It is believed that UVB inflammation releases a number of vasoactive inflammatory 
mediators acting directly on the vasculature (Angst et al., 2008). Several studies have also 
demonstrated that this response also involves a neurogenic component as repeated capsaicin 
administration prior to UVB irradiation can reduce or even block this reaction (Benrath et al., 2001; 
Benrath et al., 1995; Rukwied et al., 2008). Recent studies have found an increase in production of 
nitric oxide (NO) by keratinocytes following UVB irradiation, showing that NO may also have an 
important role in inducing vasodilatation and erythema after irradiation (Clydesdale et al., 2001). In 
fact, Rhodes and collaborators used microdialysis technique in the UVB irradiated skin and 
confirmed that NO is one of the most important inflammatory mediators released that can directly 
be involved in the skin response to UVB irradiation (Clough and Church 2002; Rhodes et al., 2001).  
In Study II of the PhD project, the change in skin perfusion was evaluated in the skin after 
UVB irradiation and eccentric activity. The results of that study confirmed that UVB induced a 
significant increase in vasodilatation in the irradiated area and up to 2 cm outside the UVB 
irradiated area. The same study (II), also reported a small increase in blood flow in the DOMS area 
up to 2 cm away from the irradiated site, probably caused by the muscular inflammatory process 
induced by DOMS. As already mentioned, the release of inflammatory markers and neutrophils as a 
consequence of the muscle traumas induced by eccentric activity might be the cause of this increase 
in cutaneous blood flow. 
Data collected when combining the two pain model (UVB and DOMS), showed an increase 
in blood flow which was higher than values found in the DOMS site alone. This result might be a 
direct consequence of a potentiation of the responses when the two models are applied in 
combination. Moreover, when combining the two models, the increase in blood flow was smaller 
than the increase found in the UVB area, where only the irradiation was applied. It is possible to 
speculate that this result may be due to difference in cutaneous perfusion between lower and upper 
part of the back. 
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Figure 6. Mean (± SEM, N = 16) skin blood flow in arbitrary units (AU) before and 24 h after 
UVB irradiation inside and outside the area irradiated on the arm. Data taken from Study I. 
 
6.2 Skin hyperalgesia to mechanical stimulation 
 
In addition to the primary hyperalgesia, several studies have investigated the development of 
secondary hyperalgesia following cutaneous UVB irradiation using a wide range of different 
methodologies, for example, the 10 g von Frey filament used by Bishop and coworkers, the 
electronic  von Frey system used by Harrison and the 150 g rigid von Frey filament used by 
Gustorff and collaborators (Bishop et al., 2009; Gustorff et al., 2004b; Gustorff et al., 2013; 
Harrison et al., 2004). All these studies found contradictory results leading to the conclusion that the 
type of filament used in the assessment of skin hyperalgesia, might influence the outcome.  
In this PhD project a pronounced cutaneous mechanical hyperalgesic area was present within the 
irradiated area 24 h after irradiation probably caused by the activation of Aδ and C fibres as a direct 
consequence of the release of pro-inflammatory mediators after tissues injury. This finding related 
to the existence of an area of primary hyperalgesia after UVB irradiation,  is in agreement with the 
studies carried out by Bishop and Harrison (Bishop et al., 2009; Harrison et al., 2004).  Moreover, 
in agreement with the finding of Gustorff and collaborators, an area of secondary hyperalgesia was 
demonstrated outside the irradiated area using weight-calibrated pin-pricks (Gustorff et al., 2004b; 
Gustorff et al., 2013). These findings are shown in Fig 7. 
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Figure 7. Mean (± SEM, N = 16) pin-prick pain thresholds (weight calibrated pin-prick instrument) 
before and 24 h after UVB irradiation inside and outside the area irradiated in the back. Data taken 
from Study II. 
 
Based on the finding of this study and in the light of the results provided by other authors it is 
possible to conclude that in the assessment of skin hyperalgesia, the assessment modality used is 
highly important. This can explain why Bishop et al. (2009) could not map any area of secondary 
hyperalgesia after UVB irradiation. The light 10 g von Frey filament used in their study was not the 
optimal choice for demonstration of secondary hyperalgesia since this filament is not painful in 
normal skin. Moreover, in the assessment of mechanical hyperalgesia, the pin-prick represents a 
better choice with respect to the Von Frey hairs since the pressure exerted by the pin-prick 
stimulator is only related to the calibrated weight of the stimulator with no bias caused by the force 
applied by the investigator.  
In a recent study by Rössler and collaborators, it was demonstrated that after UVB irradiation, the 
area of secondary hyperalgesia to pin-prick was not reduced by application of local anesthetics, 
suggesting the influence of a centrally-mediated mechanisms (Rössler et al., 2013).  
When combining the UVB model with eccentric activity in the underlying muscle, the magnitude of 
decrease in pin-prick thresholds found in the location where the two models were combined 
presented no difference compared with the decrease found in the UVB location suggesting that the 
decrease in mechanical pain threshold could only be due to the effect of cutaneous UVB 
inflammation without any convergent facilitation or potentiating effect between skin and deep 
tissues hyperalgesia.  
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6.3 Pressure pain sensitivity by pressure algometry 
 
Pressure algometry has been used for decades for the assessment of sensitivity to pain. In the first 
experiment the pressure pain sensitivity was evaluated after UVB irradiation of the skin. As showed 
for the mechanical pain threshold, the UVB irradiation induces an area of primary and secondary 
hyperalgesia to pressure stimuli (Fig 8). In this PhD project it was also hypothesized that the 
reduction in pressure pain thresholds both inside and outside the irradiated area may be influenced 
by sensitized responses of deep-tissue nociceptors. Anyway, no difference was found between the 
decrease in PPT in the UVB area and the decrease found in the area where the UVB and DOMS 
models were applied in combination. These findings suggest that the decrease in PPT might be only 
due to the cutaneous UVB inflammation and that DOMS does not have any effect on the UVB-
related cutaneous hyperalgesia. A possible explanation for the lack of DOMS effect on PPT can be 
found in the model itself as already mentioned - it does not induce an equal level of muscle soreness 
in all subjects or the exercises protocol applied in this study did not induce an adequate level of 
muscle hyperalgesia. 
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Figure 8. Pain pressure threshold maps before (A) and after (B) irradiation in the arm. The numbers 
indicate the points of stimulation, with points 3 and 7 are oriented towards the wrist, and points 6 
and 10 towards the elbow. The maps are based on interpolated mean values (N = 16) from 
assessments with the 0.5 cm2 flat probe. Data taken from Study I. 
 
6.3.1 The effect of probe design on skin and deep-tissues 
 
It is well known that probe shape and diameter are important factors in the assessment of pressure 
pain. Using computer models, previous studies demonstrated that probes with surface area larger 
than 1cm2 can give a better evaluation of pain threshold in deep tissues, as the activation of muscle 
nociceptors is related to the deformation of the muscle tissue (Finocchietti et al., 2011; Takahashi 
and Mizumura 2004; Takahashi et al., 2005). In this PhD project four probes, different in shape and 
diameter, have been used: a flat tip probe with a diameter of 2.0 cm2, a flat tip probe with a 
diameter of 1.0 cm2, a flat tip probe with a diameter of 0.5 cm2, and a V-shaped probe with a flat 
contact surface of 0.03 cm2, the last one specially designed to elicit cutaneous pressure pain (Fig 
4B). In order to minimize the painful skin stimuli coming from the sharp contact edges of the 2.0 
cm2, 1.0 cm2, 0.5 cm2 probes, these probes are covered with a rubber disc (Finocchietti et al., 2011). 
In Studies I and II it was found that the PPTs detected with the smallest probe (0.03 cm2) were 
smaller than the thresholds detected with the other three larger probes (2.0 cm2, 1.0 cm2, 0.5 cm2) 
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when the data are not adjusted for the probe area. Those findings suggest that with small probes less 
absolute force is required to induce pain than using probes with a large diameter (> 1cm2). This is in 
line with the findings by other authors reporting increasing threshold with increasing probe size 
(Greenspan and McGillis 1991; Jensen et al., 1986). Moreover, the decrease after UVB irradiation 
in PPT and PPTO using 2 cm2 and 1 cm2 probes suggests that the use of larger probes may lead to 
activation of both skin and deeper tissues nociceptors after induction of hyperalgesia or that these 
probes also stimulate the skin. This is in line with the findings reported by several studies where the 
authors tried to eliminate the contribution of the skin to pressure stimulation by inducing cutaneous 
anaesthesia (Graven-Nielsen et al., 2004; Kosek et al., 1999; Laursen et al., 1997). In all these 
studies, the authors concluded that also the inputs coming from the skin are involved in the 
assessment of pressure pain sensitivity in deep tissues.  
 
6.3.2 Stimulus-Response Curve (SR curve) 
 
The stimulus-response functions is a curve where graded pressure stimulations is related to pain 
intensity recorded trough a VAS. Most pressure algometry studies have not assessed the complete 
stimulus-response function. This PhD study is the first to assess how the pressure-intensity versus 
pain-intensity function is modulated in response to skin irradiation alone or in combination with 
DOMS-induced deep tissue soreness (Studies I and II). The data reported in Study I illustrated that, 
with all probes, 24 h after UVB irradiation, the stimulus response curve showed a left-shift and an 
increased slope both within and outside the UVB-irradiated area compared with baseline recordings 
with the most pronounced left-shift within the irradiated area (Fig 9). The left-shift of the stimulus-
response curve results in lowering of the pain thresholds (allodynia) and an increase in pain to 
suprathreshold stimuli (hyperalgesia, Fig 1). This confirms the presence of areas of primary and 
secondary hyperalgesia to mechanical pressure stimuli induced by UVB irradiation. The Study I 
also revealed that the probe shape has an influence on the SR slope. In fact the analysis of the slope 
for the V-shaped probe suggests that the subjects raised the VAS scale faster with the smallest 
probe than with the other three probes both inside and outside the irradiated area. A possible 
explanation is that the cutaneous sensitization is more affected by the V-shaped probe than others 
probes. The data collected in the second experiment indicated that DOMS alone induced a left-shift 
of the stimulus-response curve and an increased slope, 24 h after eccentric exercises, but no additive 
effects were reported when combining the UVB and DOMS models together.  The stimulus-
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response function is based on the pain intensity recorded by VAS scale. The VAS scale is also one-
dimensional without any information about pain quality. For this reason, in future studies it could 
be useful to use McGill pain questionnaire or other descriptors of pain to assess also the quality of 
pain besides its intensity. 
 
 
Figure 9. Pressure intensity versus VAS scores inside (A) and outside (B) the irradiated area on the 
back. The data are taken from Study I and the stimulus-response curves are based on the average of 
16 subjects from assessments with the 0.5 cm2 probe. Before irradiation (red curve), the VAS score 
increases moderately fast with increasing pressure stimulus intensity. After irradiation (blue curve), 
the stimulus-response curve is shifted to the left; indicating that a lower pressure is necessary to 
induce pain and an increased response to suprathreshold stimuli. 
 
6.3.3 Temporal summation of pain 
 
Temporal summation of pain (TSP) is the progressively increase of VAS score in response to 
repetitive pressure stimulations of the same strength and is thought to mimic the wind-up process 
occurring in dorsal horn neurons. This is a mechanism where the sensitivity of the neurons in the 
dorsal horn to C-fibre input can be intensified by repetitive stimulation (Hayashi et al., 2013; 
Mendell and Wall 1965). TSP to repetitive pressure stimulations has been used in skin and deep 
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tissues with electrical, mechanical and thermal stimuli (Arendt-Nielsen et al., 1994; Nie et al., 
2009a; Staud et al., 2003) and in patients with chronic musculoskeletal pain it has been 
demonstrated that TSP is facilitated compared with healthy controls (Arendt-Nielsen et al., 2010; 
Staud et al., 2003). The TSP indicates that the increasing pain perception after repetitive stimulation 
having the same intensity is due to a central mechanism (Arendt-Nielsen et al., 1994; Nie et al., 
2009b; Staud et al., 2003). In this PhD project, the TSP was evaluated using a sequential 
stimulation of 10 pressure stimuli, all equal to the subjective pain threshold. After the recording, the 
VAS score corresponding to each stimulus was extracted. In order to show the pure effect of TSP 
following the 10 stimuli, the values were normalized by subtracting the first VAS score from all the 
10 values recorded. In the second study, it was found that UVB irradiation induced facilitated 
temporal summation in the irradiated area (Fig 10). It was also found that TSP was not affected by 
DOMS. This result might be explained, as already mentioned, by the lack of effect of the exercises 
protocol applied and is in contrast with several studies reporting facilitated temporal summation 
after eccentric activity (Bajaj et al., 2000; Nie et al., 2006). Moreover, no additional increase in TSP 
was found in the UVB+DOMS location compared to the UVB location suggesting that the 
phenomenon of TSP might be only due to the central effect induced by UVB-model (Fig 10). The 
presence of temporal summation induced by UVB irradiation can be considered of highly 
importance when testing analgesics having central effects.  
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Figure 10. Mean (± SEM, N = 16) of the sum of the VAS scores (VAS sum) recorded before and 
after irradiation/exercise assessed with the 2 cm2 flat probe. The VAS scores have been normalized 
by subtracting the first VAS score from all the 10 values and then the VAS sum was calculated. 
Data taken from Study II. 
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6.4 Effect of local cutaneous anesthesia on the UVB- inflammatory model 
 
In order to understand whether the effect of UVB irradiation on both areas of primary and 
secondary hyperalgesia is of peripheral or central origin, the effect of topical anesthetic application 
on the UVB-induced primary and secondary hyperalgesia was evaluated. EMLA cream was applied 
24 h after UVB irradiation. The EMLA anesthetic cream is a mixture of equal parts of lidocaine and 
prilocaine (1 g of cream contains 25 mg of lidocaine and 25 mg of prilocaine) and is usually used in 
clinical practice during surgery to decrease pain from cutaneous procedure in both adults and 
children (Taddio et al., 1998). It has also been proved that EMLA cream induces analgesia on 
normal skin and also in skin affected by dermatological conditions such as hyperhidrosis or 
postherpetic neuralgia (Lycka 1992). A study conducted by Arendt-Nielsen and collaborators, 
reported  that the depth of analgesia induced by topical application of EMLA cream is about 5 mm 
(Arendt-Neilsen et al., 1989). It has been also proved that several factors may influence the 
anesthetic effect of the EMLA, such as the anatomical region where the cream is applied and the 
thickness of the skin (Arendt-Neilsen et al., 1989; Bjerring and Arendt-Nielsen 1990; Nielsen et al., 
1992). In order to be effective, after its application the EMLA cream has to be covered in an 
occlusive dressing. Several studies have reported erythema and skin pallor after application of 
EMLA under occlusive dressing probably as a consequence of vasoactive properties of both 
lidocaine and prilocaine (Tahir et al., 2006). The results of Study I showed an increase in cutaneous 
pin-prick threshold following application of EMLA cream in uninjured skin, demonstrating that 
EMLA cream is able to induce hypoalgesia in intact skin.  Results (Study I) also demonstrate that 
EMLA cream does not have anesthetic effect on the PPT or on the pin prick hyperalgesia on the 
UVB+EMLA area. A possible explanation of those findings can be related with the timing of 
application of the anesthetics. In this experiment the EMLA cream was applied on top of the 
irradiated area only 24 h after irradiation, when the UVB-induced hyperalgesia was already well-
established. This may indicate that EMLA cream is only able to prevent the development of 
hyperalgesia if applied prior intervention, but it is not able to reverse the hyperalgesia after its full 
establishment. The most likely explanation is that the EMLA cream does not block the skin receptor 
once they have been sensitized. This is in line with the results of the study conducted by Rössler 
and collaborators in healthy volunteers (Rössler et al., 2013). In their study they concluded that the 
presence of mechanical hyperalgesia in the irradiated area was not altered by peripheral afferent 
blockade with local lidocaine anesthetic agent at 4 h after UVB irradiation (Rössler et al., 2013).  It 
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is also possible that the skin works as a barrier to the cream diffusion making difficult to understand 
the amount of EMLA cream that actually reaches the nociceptors. 
Study I also revealed unchanged pressure pain sensitivity after anesthetic application. This is in line 
with different studies reporting unchanged or even decreased PPT after EMLA administration 
(Graven-Nielsen et al., 1998; Graven-Nielsen et al., 2004; Kosek et al., 1995; Laursen et al., 1997). 
This result may indicate that also the deeper-structures beneath the UVB-irradiated skin could be 
sensitized possibly through a convergence of mechanisms involving both skin and deep tissues 
somatic nociceptors. 
 
6.5 Interaction between Skin and Deep Tissues 
 
The phenomenon of interaction between skin and deep tissues can be explained with the 
convergence-projection model, where afferent fibres coming from different areas as muscle and 
skin may make synaptic contact with the same dorsal horn neuron (Graven-Nielsen 2006; Hoheisel 
and Mense 1990). The existence of a possible convergence between afferent nociceptive fibres from 
superficial and deep structures has been already demonstrated in several studies (Hoheisel and 
Mense 1990; Yu and Mense 1990).   
What is still unknown and what was evaluated in the second and in the third studies of this PhD 
project was the manifestation of a possible convergence between deep and superficial tissues when 
those inflammatory models of skin and muscle were applied in combination. It was hypothesized 
that when both models were applied, the increase in sensitivity will be superior with respect to the 
individual reactions. 
The data reported after combination of cutaneous and deep tissue pain models in Study II indicates 
possible additive effect between the two models mediating the neurogenic inflammation, since the 
increase in blood flow in the area where the two models were applied in combination was higher 
than the increase present in the DOMS site (Fig 11AB), whereas no additive effect between the two 
models was present on data regarding mechanical hyperalgesia (Fig 11CD). These findings suggest 
that different mechanisms of neuronal convergence between deep and superficial somatic tissues 
might mediate processes of neurogenic inflammation and hyperalgesia. 
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Figure 11. Mean (± SEM, N = 16) of blood flow (AB) and pressure pain threshold (CD) recorded 
before and after exercise and irradiation/exercise. The PPT has been assessed with the 2 cm2 flat 
probe. Data taken from Study II. 
 
6.6 UVB-induced areas of allodynia and hyperalgesia  
 
The UVB model is one of the best characterized models of peripheral sensitization, since it induces 
primary hyperalgesia peaking between 24 and 48 h both in animals and humans (Weerasinghe et al., 
2014). However, the existence of secondary hyperalgesia as a consequence of UVB irradiation has 
always been controversial and has been confirmed only by some groups (Davies et al., 2011; 
Gustorff et al., 2013; Weerasinghe et al., 2014). In different studies, conducted on both rats and 
humans, the authors agreed that the UVB-model is able to induce both areas of secondary allodynia 
and hyperalgesia through induction of central sensitization (Davies et al., 2011; Gustorff et al., 
2013; Weerasinghe et al., 2014). The findings of Study III are in line with the results of these 
groups and demonstrated that UVB irradiation of the skin induces primary areas of allodynia and 
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hyperalgesia lasting up to 3 days, caused by the sensitization of peripheral nociceptors in the skin.  
Moreover, the UVB model also induced secondary areas of allodynia and hyperalgesia probably 
due to sensitization of dorsal horn neurons (Fig 12). The presence of secondary hyperalgesia after 
UVB irradiation is important to clarify the neural mechanism underling inflammatory pain and to 
better understand all the aspects of chronic pain. 
 
 
 
Figure 12. Example of mapping of the area of secondary allodynia 24, 48 and 72 h after irradiation 
in the back. The yellow square indicates the irradiated area, and the areas of allodynia have been 
mapped using a single 23 g von Frey filament. The data refers to a single subject and has been taken 
from Study III. 
 
6.7 Effect of heat rekindling in UVB-irradiated skin and NGF-sensitized muscle 
 
In the third study, the effect of heat rekindling on the areas of secondary allodynia and hyperalgesia 
induced by UVB irradiation was also investigated. It was found that application of mild heat to an 
already UVB-sensitized skin can maintain or facilitate allodynia and hyperalgesia for a longer 
period as showed on both panels of Fig 13. These results are in line with the finding of studies 
investigating the effect of the UVB and heat rekindling (UVB/HR) model in animals. The study 
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conducted by Davis and collaborators in rats provides evidence that the secondary hyperalgesic area 
induce by UVB-irradiation in the plantar hind paw was enhanced and prolonged by heat rekindling 
(Davies et al., 2011; Weerasinghe et al., 2014). In the most recent animal study, conducted by 
Weerasinghe and collaborators, the authors concluded that the increase of the area of UVB-induced 
secondary hyperalgesia after rekindling may be due to a more prolonged C-fiber input to the spinal 
cord induced by heat (Weerasinghe et al., 2014). The same conclusions have been shown by similar 
studies conducted in humans. Eisenach and co-workers investigated the effect of the 
cyclooxygenase inhibitor ketorolac on the UVB/HR model (Eisenach et al., 2010). In their study 
they concluded that heat rekindling increased the area oh hyperalgesia induced by UVB-irradiation 
and this process can be reversed by intravenous ketorolac administration (Eisenach et al., 2010). In 
conclusion, the UVB/HR model can be considered a valid tool for screening compounds having 
long lasting action.  
The third study also investigated whether the addition of muscle sensitization to a previous UVB-
sensitized skin could enhance or modified the rekindling effect. In order to avoid mechanical 
stretching of the irradiated skin caused by the eccentric contractions, the NGF model was used to 
induce deep tissues hyperalgesia. In this study it was hypothesized that the responsiveness to 
mechanical stimulation could be enhanced by a possible convergence mechanism between 
superficial and deep tissue sensory input (Fig 14). However, the data collected did not support this 
hypothesis since the muscle soreness induced by NGF did not have any effect on the UVB-induced 
areas of allodynia or to heat rekindling. These results can be due to the strong UVB effect on the 
skin masking the effect of the NGF (Study III). In the third study, the NGF was injected 24 h after 
UVB irradiation, when the UVB inflammation was full established. Modifying the time line of the 
study and performing both models  the same day may have led to different results. 
  
46 
 
 
 
Figure 13. Examples of mapping of area of secondary hyperalgesia (A) and allodynia (B) at 
baseline (72 h after irradiation) and after the I and the II heat rekindling in the arm and back 
respectively. The yellow square indicates the irradiated area. The areas of hyperalgesia have been 
mapped using a pin prick corresponding to the subject threshold, whereas the area of allodynia has 
been mapped using a single 23 g von Frey filament. The data refers to a single subject and has been 
taken from Study III. 
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Figure 14. Examples of expected timing  regarding the increase of the allodynic area  after  heat 
rekindling combined with UVB irradiation (A), NGF injection (B) or both models (C), respectively.  
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6.8 Summary and conclusions 
 
Ultraviolet-B irradiation model has been used for many years as a translational model since it is 
known to induce cutaneous inflammatory pain in both animals and humans. The aim of this PhD-
project was to evaluate time course and sensory changes following UVB irradiation by addressing 
the following points: 1) evaluate the change in vasomotor response and pain sensitivity inside and 
outside the irradiated skin, 2) investigate the existence of cumulative effects of cutaneous and deep-
tissue hyperalgesia, 3) investigate the UVB-induced mechanical hyperalgesia and allodynia after 
application of additional heat stimuli and if the response of the UVB-model to heat may be 
modified by sensitization of deep tissues. 
The results of this PhD project demonstrated that UVB irradiation of the skin provokes cutaneous 
primary hyperalgesia to mechanical and pressure stimulations, probably due to sensitization of 
peripheral nociceptors caused by the inflammatory mediators released after irradiation. Moreover, 
UVB irradiation induced an area of secondary hyperalgesia. The cutaneous-UVB model also 
induced an inflammatory reaction leading to an increase in cutaneous blood flow (Studies I and II). 
The same studies also confirmed that UVB irradiation induced a left-shift of the stimulus-response 
curve, relating pressure stimulation to pain intensity, and facilitation of temporal summation to 
repetitive pressure stimuli. Administration of topical anesthetic cream 24 h after irradiation did not 
have any effect on mechanical hyperalgesia on the UVB-irradiated area and this lacking effect 
could be due to the fact that the anesthetic used, namely the EMLA cream, might not block the skin 
receptor once they have been sensitized (Study I). 
In Study III, it was found that the UVB model induces long and stable primary areas of allodynia 
and hyperalgesia up to 72 h after skin irradiation. Both these areas can be also enhanced and 
prolonged by application of mild heat (heat rekindling, Study III). Moreover, it was also found that 
muscle hyperalgesia induced by NGF injection, does not suppress or potentiate the effect of UVB 
irradiation or heat rekindling on the areas of allodynia and hyperalgesia (Study III). 
The combination of cutaneous hyperalgesia (UVB model) and muscle hyperalgesia (DOMS) in the 
same area showed that muscle hyperalgesia may enhance the UVB-induced vasodilatation (Study 
II). The same study also confirmed that muscle hyperalgesia induced by DOMS does not induce any 
change in UVB-induced cutaneous hyperalgesia. 
In conclusion, the UVB-model can be considered a long-lasting and non-invasive experimental 
model of primary and secondary hyperalgesia, and a valid tool for screening of new analgesic 
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medications, active at both peripheral and central level. Moreover, it can also be used in pain 
research as a translational model, from animals to healthy subjects. 
 
6.9 Perspectives and Implications 
 
The results of this PhD project will help in validating the UVB model as a non-invasive and 
prolonged human experimental model that can be used for development and testing of new 
analgesic medications. Moreover, the finding related to the induction of primary and secondary 
hyperalgesia underline the importance of the UVB model as a tool for screening of new drugs 
having different mechanisms of action. In the longer perspectives it may lead to the development of 
better treatment regimens and thus a more effective treatment of patients with acute and chronic 
pain. In order to test the prophylactic effects of an anti-inflammatory drug, the measurement of 
biomarkers in serum samples could represents a valid tool in the future for testing the mechanism of 
action of tested drugs. Moreover, in order to clarify the involvement of central mechanisms in the 
UVB irradiation model, the future studies are recommended to test whether the administration of an 
anti-inflammatory drug prior irradiation can block the development of allodynia and hyperalgesia in 
skin.  
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7 Dansk Sammenfatning 
 
I mange år har ultraviolet-B (UVB) bestrålingsmodellen været anvendt som en translatorisk model, 
idet den er kendt for at kunne inducere inflammatorisk kutansmerte hos både dyr og mennesker. 
Formålet med denne ph.d.-afhandling var at vurdere tidsforløbet og de sensoriske ændringer efter 
UVB-bestråling ved hjælp af følgende: 1) Evaluere ændringen i det vasomotoriske respons og 
smertefølsomheden i og uden for det bestrålede hudområde, 2) Undersøge akkumulerede effekter af 
hyperalgesi og i overfladisk og dybt væv, 3) Undersøge UVB-induceret mekanisk hyperalgesi og 
allodyni efter påføring af yderligere varmestimuli samt om UVB-modellens respons til varme kan 
modificeres ved hjælp af sensibilisering af dybt væv.   
Resultaterne af afhandlingen viste, at UVB-bestråling af huden udløser primær kutan hyperalgesi til 
mekanisk stimulation og trykpåføring; sandsynligvis grundet den sensibilisering af de perifere 
nociceptorer, der forårsages af de inflammatoriske mediatorer, som frigives efter bestrålingen. 
Endvidere resulterede UVB-bestrålingen i et område med sekundær hyperalgesi. Den kutane UVB-
model forårsagede også en inflammatorisk reaktion, som førte til en stigning i den kutane 
blodgennemstrømning (Studie I og II). Disse studier bekræftede også, at UVB-bestråling forårsager 
en venstre-forskydning i stimulusrespons-kurven der relaterer trykstimulation til smerteintensitet og 
facilitering af temporal summation af smerte til gentagne trykstimuli. Påføring af bedøvende creme 
24 timer efter bestrålingen havde ingen virkning på den mekaniske hyperalgesi i det UVB-
bestrålede område; denne manglende virkning kan skyldes, at den anvendete creme, nemlig EMLA-
creme, måske ikke blokerer receptorerne i huden tilstrækkeligt, når de er sensibiliseret (Studie I).  
Studie III viste, at UVB-modellen påfører stabile primære områder med allodyni og hyperalgesi i op 
til 72 timer efter bestråling af huden. Virkningen i begge disse områder kan også forstærkes og 
forlænges ved påføring af let varme (genfremkaldes vha. varme, Studie III). Endvidere viste det sig, 
at eksperimentel muskelhyperalgesi induceret vha. NGF-injektioner hverken dæmper eller forøger 
effekten af UVB-bestråling eller genfremkaldelsen i områder med allodyni og hyperalgesi (Studie 
III).  
Kombinationen af kutan hyperalgesi (UVB-modellen) og muskulær hyperalgesi (DOMS) i samme 
område viste, at muskelhyperalgesi kan forstærke den UVB-inducerede kardilatation (Studie II). 
Dette studie bekræftede også, at muskelhyperalgesi, som induceres vha. DOMS, ikke forårsager 
ændringer i UVB-induceret hyperalgesi i hud.  
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Det konkluderes, at UVB-modellen kan ses som en langtidsvirkende og non-invasiv eksperimentel 
model for primær og sekundær kutan hyperalgesi og som en interessant model til screening af ny 
smertestillende medicin virkende på både perifert og centralt niveau, herunder som en translatorisk 
model fra dyr til raske forsøgspersoner.  
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